ImmunityBio (IBRX) Earnings Date & Reports

ImmunityBio Inc is a biotechnology company focused on developing and commercializing next-generation immunotherapies designed to activate the patient's immune system and provide durable protection against cancer and infectious diseases... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

IBRX is expected to report earnings to fall 88.92% to -6 cents per share on August 12

Q2'26

Est.

$-0.07

Q1'26

Missed

by $0.55

Q4'25

Beat

by $0.05

Q3'25

Beat

by $0.04

Q2'25

Beat

by $0.01

The last earnings report on May 07 showed earnings per share of -62 cents, missing the estimate of -7 cents. With 10.52M shares outstanding, the current market capitalization sits at 8.38B.

View a ticker or compare two or three

Compare

IBRX

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

View AI-Driven Trading for IBRX

A.I. Advisor